Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

VALERIE DIANE ESPINOSA

Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism

NPI
1649245697
CMS profile
120305
Location
AUSTIN, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$80.44

4 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $80.44 4

By paying entity

PY2024 · entire year · sorted by reported total

Paying entityAmountRecords
Amgen Inc. $34.00 2
Medtronic, Inc. $24.31 1
Abbott Laboratories $22.13 1

Page 1 of 1; records 1–4 of 4 matching records. This page contains 4 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

VALERIE DIANE ESPINOSA

NPI 1649245697 · CMS profile ID 120305

Allopathic & Osteopathic Physicians / Internal Medicine / Endocrinology, Diabetes & Metabolism

AUSTIN, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–4 of 4 matching records. This page contains 4 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1649245697?year=2024&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
VALERIE DIANE ESPINOSA, NPI 1649245697, CMS profile ID 120305. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–4 of 4 matching records. This page contains 4 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1649245697?year=2024&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). VALERIE DIANE ESPINOSA, NPI 1649245697, CMS profile ID 120305. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–4 of 4 matching records. This page contains 4 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1649245697?year=2024&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
VALERIE DIANE ESPINOSA, NPI 1649245697, CMS profile ID 120305, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–4 of 4 matching records. This page contains 4 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1649245697?year=2024&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

4 matching records · $80.44 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 4 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–4 of 4.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Amgen Inc. $18.4711/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1115606634 CMS
Abbott Laboratories $22.1305/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1125168592 CMS
Medtronic, Inc. $24.3105/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1119415358 CMS
Amgen Inc. $15.5303/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1115606628 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $16.77 1
PY2020 $2,295.00 1
PY2021 $180.01 9
PY2022 $102.32 6
PY2023 $158.18 9
PY2024 $80.44 4
PY2025 $190.15 9

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $6,754.50 7
PY2024 Principal investigator $16,033.58 16
PY2023 Principal investigator $23,025.89 42
PY2022 Recipient $4,540.00 1
PY2022 Principal investigator $427,933.76 272
PY2021 Principal investigator $331,661.14 458
PY2020 Principal investigator $107,369.32 113
PY2019 Principal investigator $258,474.85 102

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

273 records in PY2022

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Novo Nordisk AS $673.32 12/21/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 897010839
Principal investigator 1 Novo Nordisk AS $1,296.00 12/21/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897086229
Principal investigator 1 Novo Nordisk AS $5.41 12/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 896856801
Principal investigator 1 Novo Nordisk AS $5.41 12/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 896867847
Principal investigator 1 Novo Nordisk AS $5.41 12/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 896895585
Principal investigator 1 Novo Nordisk AS $5.41 12/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 896931669
Principal investigator 1 Novo Nordisk AS $5.41 12/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 896953105
Principal investigator 1 Novo Nordisk AS $5.41 12/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 896953110
Principal investigator 1 Novo Nordisk AS $5.41 12/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 896953689
Principal investigator 1 Novo Nordisk AS $5.41 12/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 896963271
Principal investigator 1 Novo Nordisk AS $5.41 12/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 896963275
Principal investigator 1 Novo Nordisk AS $5.41 12/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 897010847
Principal investigator 1 Novo Nordisk AS $5.41 12/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 897010851
Principal investigator 1 Novo Nordisk AS $5.41 12/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 897030491
Principal investigator 1 Novo Nordisk AS $5.41 12/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 897039737
Principal investigator 1 Novo Nordisk AS $5.41 12/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 897039741
Principal investigator 1 Novo Nordisk AS $5,266.13 11/30/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897001813
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $900.00 11/29/2022 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY PA
PARADIGHM A NATURAL HISTORY REGISTRY FOR PATIENTS WITH CHRONIC HYPOPARATHYROIDISM No dispute reported 06/30/2026 937178975
Principal investigator 1 Novo Nordisk AS $23.06 11/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 897010843
Principal investigator 1 Ascendis Pharma, Inc. $1,372.50 11/18/2022 Non-covered Recipient Entity
Texas Diabetes & Endocrinology
PaTHway TRIAL No dispute reported 06/30/2026 954364107
Principal investigator 1 Novo Nordisk AS $422.15 10/21/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 896950753
Principal investigator 1 Novo Nordisk AS $100.00 10/21/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 896950757
Principal investigator 1 Novo Nordisk AS $5,310.01 10/21/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897035624
Principal investigator 1 Ascendis Pharma, Inc. $500.00 10/06/2022 Non-covered Recipient Entity
Texas Diabetes & Endocrinology
PaTHway TRIAL No dispute reported 06/30/2026 954363863
Principal investigator 1 Novo Nordisk AS $300.00 09/28/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 896953829
Principal investigator 1 Novo Nordisk AS $7,371.86 09/28/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897061707
Principal investigator 1 Novo Nordisk AS $9,517.53 08/22/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897061701
Principal investigator 1 Ascendis Pharma, Inc. $2,053.75 08/11/2022 Non-covered Recipient Entity
Texas Diabetes & Endocrinology
PaTHway TRIAL No dispute reported 06/30/2026 954363345
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $300.00 08/02/2022 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY PA
PARADIGHM A NATURAL HISTORY REGISTRY FOR PATIENTS WITH CHRONIC HYPOPARATHYROIDISM No dispute reported 06/30/2026 937172271
Principal investigator 1 Novo Nordisk AS $27.41 07/28/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897035631
Principal investigator 1 Novo Nordisk AS $414.57 07/27/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 896894905
Principal investigator 1 Novo Nordisk AS $100.00 07/27/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897022893
Principal investigator 1 Novo Nordisk AS $27.41 07/27/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897061687
Principal investigator 1 Novo Nordisk AS $12,405.41 07/27/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897192069
Principal investigator 1 Novo Nordisk AS $51.21 07/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 896961509
Principal investigator 1 Novo Nordisk AS $51.21 07/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 896961517
Principal investigator 1 Novo Nordisk AS $51.21 07/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897001805
Principal investigator 1 Novo Nordisk AS $51.21 07/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897001809
Principal investigator 1 Novo Nordisk AS $51.21 07/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897022419
Principal investigator 1 Novo Nordisk AS $51.21 07/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897022881
Principal investigator 1 Novo Nordisk AS $51.21 07/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897022897
Principal investigator 1 Novo Nordisk AS $51.21 07/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897023501
Principal investigator 1 Novo Nordisk AS $51.21 07/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897061679
Principal investigator 1 Novo Nordisk AS $51.21 07/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897061683
Principal investigator 1 Novo Nordisk AS $51.21 07/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897061781
Principal investigator 1 Novo Nordisk AS $51.21 07/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897082013
Principal investigator 1 Novo Nordisk AS $51.21 07/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897086379
Principal investigator 1 Novo Nordisk AS $51.21 07/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897100615
Principal investigator 1 Novo Nordisk AS $51.21 07/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897125441
Principal investigator 1 Novo Nordisk AS $51.21 07/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897125449
Principal investigator 1 Novo Nordisk AS $51.21 07/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897125453
Principal investigator 1 Novo Nordisk AS $51.21 07/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897130494
Principal investigator 1 Novo Nordisk AS $51.21 07/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897130497
Principal investigator 1 Novo Nordisk AS $51.21 07/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897130983
Principal investigator 1 Novo Nordisk AS $51.21 07/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897130991
Principal investigator 1 Novo Nordisk AS $51.21 07/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897131021
Principal investigator 1 Novo Nordisk AS $51.21 07/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897131149
Principal investigator 1 Novo Nordisk AS $51.21 07/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897131153
Principal investigator 1 Novo Nordisk AS $51.21 07/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897131157
Principal investigator 1 Novo Nordisk AS $51.21 07/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897133107
Principal investigator 1 Novo Nordisk AS $51.21 07/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897135465
Principal investigator 1 Novo Nordisk AS $51.21 07/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897186889
Principal investigator 1 Novo Nordisk AS $51.21 07/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897186895
Principal investigator 1 Novo Nordisk AS $51.21 07/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897187041
Principal investigator 1 Novo Nordisk AS $51.21 07/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897187046
Principal investigator 1 Novo Nordisk AS $51.21 07/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897187050
Principal investigator 1 Novo Nordisk AS $51.21 07/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897187053
Principal investigator 1 Novo Nordisk AS $51.21 07/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897187057
Principal investigator 1 Novo Nordisk AS $51.21 07/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897188521
Principal investigator 1 Novo Nordisk AS $51.21 07/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897188583
Principal investigator 1 Novo Nordisk AS $51.21 07/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897188601
Principal investigator 1 Novo Nordisk AS $51.21 07/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897188605
Principal investigator 1 Novo Nordisk AS $51.21 07/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897188609
Principal investigator 1 Novo Nordisk AS $51.21 07/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897188613
Principal investigator 1 Novo Nordisk AS $51.21 07/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897188617
Principal investigator 1 Novo Nordisk AS $51.21 07/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897191985
Principal investigator 1 Novo Nordisk AS $51.21 07/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897192049
Principal investigator 1 Novo Nordisk AS $51.21 07/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897192053
Principal investigator 1 Novo Nordisk AS $899.10 06/30/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897061693
Principal investigator 1 Novo Nordisk AS $899.10 06/30/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897100619
Principal investigator 1 Novo Nordisk AS $899.10 06/30/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897100623
Principal investigator 1 Novo Nordisk AS $899.10 06/30/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897125445
Principal investigator 1 Novo Nordisk AS $899.10 06/30/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897131197
Principal investigator 1 Novo Nordisk AS $899.10 06/30/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897192057
Principal investigator 1 Novo Nordisk AS $16,713.62 06/29/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897014280
Principal investigator 1 Novo Nordisk AS $49.72 06/29/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897145635
Principal investigator 1 Novo Nordisk AS $27.41 06/23/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897001817
Principal investigator 1 Novo Nordisk AS $14.98 06/17/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 896933226
Principal investigator 1 Novo Nordisk AS $56.90 06/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 896984341
Principal investigator 1 Novo Nordisk AS $56.90 06/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 896984353
Principal investigator 1 Novo Nordisk AS $56.90 06/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 896984357
Principal investigator 1 Novo Nordisk AS $56.90 06/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 896984361
Principal investigator 1 Novo Nordisk AS $56.90 06/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 896984373
Principal investigator 1 Novo Nordisk AS $56.90 06/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 896984445
Principal investigator 1 Novo Nordisk AS $56.90 06/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897014269
Principal investigator 1 Novo Nordisk AS $56.90 06/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897014276
Principal investigator 1 Novo Nordisk AS $56.90 06/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897014295
Principal investigator 1 Novo Nordisk AS $56.90 06/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897016183
Principal investigator 1 Novo Nordisk AS $56.90 06/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897016187
Principal investigator 1 Novo Nordisk AS $56.90 06/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897016191
Principal investigator 1 Novo Nordisk AS $56.90 06/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897016195
Principal investigator 1 Novo Nordisk AS $56.90 06/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897049563
Principal investigator 1 Novo Nordisk AS $56.90 06/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897049570
Principal investigator 1 Novo Nordisk AS $56.90 06/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897049587
Principal investigator 1 Novo Nordisk AS $56.90 06/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897049685
Principal investigator 1 Novo Nordisk AS $56.90 06/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897049693
Principal investigator 1 Novo Nordisk AS $56.90 06/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897049697
Principal investigator 1 Novo Nordisk AS $56.90 06/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897049701
Principal investigator 1 Novo Nordisk AS $56.90 06/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897092287
Principal investigator 1 Novo Nordisk AS $56.90 06/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897092335
Principal investigator 1 Novo Nordisk AS $56.90 06/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897092503
Principal investigator 1 Novo Nordisk AS $56.90 06/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897100483
Principal investigator 1 Novo Nordisk AS $56.90 06/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897100653
Principal investigator 1 Novo Nordisk AS $56.90 06/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897100681
Principal investigator 1 Novo Nordisk AS $56.90 06/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897100689
Principal investigator 1 Novo Nordisk AS $56.90 06/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897100805
Principal investigator 1 Novo Nordisk AS $56.90 06/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897138897
Principal investigator 1 Novo Nordisk AS $56.90 06/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897138901
Principal investigator 1 Novo Nordisk AS $56.90 06/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897138905
Principal investigator 1 Novo Nordisk AS $56.90 06/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897138937
Principal investigator 1 Novo Nordisk AS $56.90 06/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897138941
Principal investigator 1 Novo Nordisk AS $56.90 06/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897138945
Principal investigator 1 Novo Nordisk AS $56.90 06/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897138949
Principal investigator 1 Novo Nordisk AS $56.90 06/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897145675
Principal investigator 1 Novo Nordisk AS $56.90 06/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897145691
Principal investigator 1 Novo Nordisk AS $56.90 06/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897145805
Principal investigator 1 Novo Nordisk AS $56.90 06/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897145809
Principal investigator 1 Novo Nordisk AS $56.90 06/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897145815
Principal investigator 1 Novo Nordisk AS $56.90 06/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897146663
Principal investigator 1 Novo Nordisk AS $56.90 06/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897146667
Principal investigator 1 Novo Nordisk AS $56.90 06/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897146703
Principal investigator 1 Novo Nordisk AS $56.90 06/15/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897149065
Principal investigator 1 Novo Nordisk AS $27.41 06/02/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 896984369
Principal investigator 1 Novo Nordisk AS $27.41 06/01/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897092499
Principal investigator 1 Novo Nordisk AS $899.10 05/31/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897001829
Principal investigator 1 Novo Nordisk AS $899.10 05/31/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897035627
Principal investigator 1 Novo Nordisk AS $899.10 05/31/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897100631
Principal investigator 1 Novo Nordisk AS $899.10 05/31/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897100635
Principal investigator 1 Novo Nordisk AS $899.10 05/31/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897188587
Principal investigator 1 Novo Nordisk AS $899.10 05/31/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897188597
Principal investigator 1 Novo Nordisk AS $14,087.30 05/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897049593
Principal investigator 1 Novo Nordisk AS $100.00 05/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897049673
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $300.00 05/25/2022 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY PA
PARADIGHM A NATURAL HISTORY REGISTRY FOR PATIENTS WITH CHRONIC HYPOPARATHYROIDISM No dispute reported 06/30/2026 937168821
Principal investigator 1 Ascendis Pharma, Inc. $1,247.50 05/24/2022 Non-covered Recipient Entity
Texas Diabetes & Endocrinology
PaTHway TRIAL No dispute reported 06/30/2026 954362593
Principal investigator 1 Novo Nordisk AS $422.15 04/29/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 896962247
Principal investigator 1 Novo Nordisk AS $899.10 04/29/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897001833
Principal investigator 1 Novo Nordisk AS $899.10 04/29/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897001837
Principal investigator 1 Novo Nordisk AS $250.00 04/29/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897049589
Principal investigator 1 Novo Nordisk AS $899.10 04/29/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897100627
Principal investigator 1 Novo Nordisk AS $899.10 04/29/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897135481
Principal investigator 1 Novo Nordisk AS $14,028.52 04/29/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897146679
Principal investigator 1 Novo Nordisk AS $899.10 04/29/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897186903
Principal investigator 1 Novo Nordisk AS $899.10 04/29/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897192061
Principal investigator 1 Novo Nordisk AS $27.41 04/28/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897086233
Principal investigator 1 Novo Nordisk AS $27.41 04/27/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897086237
Recipient Eli Lilly and Company $4,540.00 04/08/2022 Covered Recipient Physician A PHASE 2 STUDY OF ONCE-WEEKLY LY3437943 COMPARED WITH PLACEBO IN PARTICIPANTS WHO HAVE OBESITY OR ARE OVERWEIGHT WITH WEIGHT-RELATED COMORBIDITIES No dispute reported 06/30/2026 917815709
Principal investigator 1 Novo Nordisk AS $27.41 04/07/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 896985027
Principal investigator 1 Novo Nordisk AS $27.41 04/06/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897145801
Principal investigator 1 Novo Nordisk AS $899.10 04/03/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897086225
Principal investigator 1 Novo Nordisk AS $899.10 04/03/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897125437
Principal investigator 1 Novo Nordisk AS $899.10 04/03/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897135473
Principal investigator 1 Novo Nordisk AS $85.35 04/01/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897014253
Principal investigator 1 Novo Nordisk AS $85.35 04/01/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897014271
Principal investigator 1 Novo Nordisk AS $85.35 04/01/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897014292
Principal investigator 1 Novo Nordisk AS $85.35 04/01/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897014300
Principal investigator 1 Novo Nordisk AS $85.35 04/01/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897016167
Principal investigator 1 Novo Nordisk AS $85.35 04/01/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897016171
Principal investigator 1 Novo Nordisk AS $85.35 04/01/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897017365
Principal investigator 1 Novo Nordisk AS $85.35 04/01/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897049555
Principal investigator 1 Novo Nordisk AS $85.35 04/01/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897049559
Principal investigator 1 Novo Nordisk AS $85.35 04/01/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897049677
Principal investigator 1 Novo Nordisk AS $85.35 04/01/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897049681
Principal investigator 1 Novo Nordisk AS $85.35 04/01/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897049689
Principal investigator 1 Novo Nordisk AS $85.35 04/01/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897092183
Principal investigator 1 Novo Nordisk AS $85.35 04/01/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897092331
Principal investigator 1 Novo Nordisk AS $85.35 04/01/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897092491
Principal investigator 1 Novo Nordisk AS $85.35 04/01/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897092495
Principal investigator 1 Novo Nordisk AS $85.35 04/01/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897100641
Principal investigator 1 Novo Nordisk AS $85.35 04/01/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897100645
Principal investigator 1 Novo Nordisk AS $85.35 04/01/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897100649
Principal investigator 1 Novo Nordisk AS $85.35 04/01/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897100657
Principal investigator 1 Novo Nordisk AS $85.35 04/01/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897100661
Principal investigator 1 Novo Nordisk AS $85.35 04/01/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897100665
Principal investigator 1 Novo Nordisk AS $85.35 04/01/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897100669
Principal investigator 1 Novo Nordisk AS $85.35 04/01/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897100673
Principal investigator 1 Novo Nordisk AS $85.35 04/01/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897101119
Principal investigator 1 Novo Nordisk AS $85.35 04/01/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897138893
Principal investigator 1 Novo Nordisk AS $85.35 04/01/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897138917
Principal investigator 1 Novo Nordisk AS $85.35 04/01/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897138921
Principal investigator 1 Novo Nordisk AS $85.35 04/01/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897138925
Principal investigator 1 Novo Nordisk AS $85.35 04/01/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897138933
Principal investigator 1 Novo Nordisk AS $85.35 04/01/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897145663
Principal investigator 1 Novo Nordisk AS $85.35 04/01/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897145667
Principal investigator 1 Novo Nordisk AS $85.35 04/01/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897145671
Principal investigator 1 Novo Nordisk AS $85.35 04/01/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897145687
Principal investigator 1 Novo Nordisk AS $85.35 04/01/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897145785
Principal investigator 1 Novo Nordisk AS $85.35 04/01/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897145789
Principal investigator 1 Novo Nordisk AS $85.35 04/01/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897145793
Principal investigator 1 Novo Nordisk AS $85.35 04/01/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897145797
Principal investigator 1 Novo Nordisk AS $85.35 04/01/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897146675
Principal investigator 1 Novo Nordisk AS $85.35 04/01/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897146687
Principal investigator 1 Novo Nordisk AS $85.35 04/01/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897146691
Principal investigator 1 Novo Nordisk AS $85.35 04/01/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897146699
Principal investigator 1 Novo Nordisk AS $899.10 03/31/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897022889
Principal investigator 1 Novo Nordisk AS $899.10 03/31/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897057357
Principal investigator 1 Novo Nordisk AS $899.10 03/31/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897061697
Principal investigator 1 Novo Nordisk AS $899.10 03/31/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897086221
Principal investigator 1 Novo Nordisk AS $899.10 03/31/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897130987
Principal investigator 1 Novo Nordisk AS $899.10 03/31/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897192065
Principal investigator 1 Novo Nordisk AS $14,157.90 03/28/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897092299
Principal investigator 1 Novo Nordisk AS $187.50 03/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 896895589
Principal investigator 1 Ascendis Pharma, Inc. $2,780.00 03/22/2022 Non-covered Recipient Entity
Texas Diabetes & Endocrinology
PaTHway TRIAL No dispute reported 06/30/2026 954360613
Principal investigator 1 Novo Nordisk AS $27.41 03/17/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897100487
Principal investigator 1 Novo Nordisk AS $27.41 03/16/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897049577
Principal investigator 1 Novo Nordisk AS $27.41 03/04/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897145679
Principal investigator 1 Novo Nordisk AS $27.41 03/03/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897049515
Principal investigator 1 Novo Nordisk AS $27.41 03/03/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897092291
Principal investigator 1 Novo Nordisk AS $27.41 03/02/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897138909
Principal investigator 1 Novo Nordisk AS $899.10 02/28/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897022885
Principal investigator 1 Novo Nordisk AS $899.10 02/28/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897081809
Principal investigator 1 Novo Nordisk AS $899.10 02/28/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897125433
Principal investigator 1 Novo Nordisk AS $899.10 02/28/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897131875
Principal investigator 1 Novo Nordisk AS $899.10 02/28/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897135469
Principal investigator 1 Novo Nordisk AS $899.10 02/28/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897135477
Principal investigator 1 Novo Nordisk AS $15,849.35 02/25/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897145683
Principal investigator 1 Novo Nordisk AS $27.41 02/24/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897145658
Principal investigator 1 Ascendis Pharma, Inc. $6,938.75 02/23/2022 Non-covered Recipient Entity
Texas Diabetes & Endocrinology
PaTHway TRIAL No dispute reported 06/30/2026 954360063
Principal investigator 1 Novo Nordisk AS $27.41 02/23/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897145655
Principal investigator 1 Ascendis Pharma, Inc. $200.00 02/15/2022 Non-covered Recipient Entity
Texas Diabetes & Endocrinology
PaTHway TRIAL No dispute reported 06/30/2026 954360019
Principal investigator 1 Novo Nordisk AS $29.94 02/10/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 896984345
Principal investigator 1 Novo Nordisk AS $29.94 02/10/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 896984349
Principal investigator 1 Novo Nordisk AS $29.94 02/10/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897014065
Principal investigator 1 Novo Nordisk AS $29.94 02/10/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897014265
Principal investigator 1 Novo Nordisk AS $29.94 02/10/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897014284
Principal investigator 1 Novo Nordisk AS $29.94 02/10/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897014287
Principal investigator 1 Novo Nordisk AS $29.94 02/10/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897049547
Principal investigator 1 Novo Nordisk AS $29.94 02/10/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897049551
Principal investigator 1 Novo Nordisk AS $29.94 02/10/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897049583
Principal investigator 1 Novo Nordisk AS $29.94 02/10/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897092279
Principal investigator 1 Novo Nordisk AS $29.94 02/10/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897092283
Principal investigator 1 Novo Nordisk AS $29.94 02/10/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897092311
Principal investigator 1 Novo Nordisk AS $29.94 02/10/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897092319
Principal investigator 1 Novo Nordisk AS $29.94 02/10/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897092323
Principal investigator 1 Novo Nordisk AS $29.94 02/10/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897092327
Principal investigator 1 Novo Nordisk AS $29.94 02/10/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897092483
Principal investigator 1 Novo Nordisk AS $29.94 02/10/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897092487
Principal investigator 1 Novo Nordisk AS $29.94 02/10/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897092511
Principal investigator 1 Novo Nordisk AS $29.94 02/10/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897100491
Principal investigator 1 Novo Nordisk AS $29.94 02/10/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897100637
Principal investigator 1 Novo Nordisk AS $29.94 02/10/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897138114
Principal investigator 1 Novo Nordisk AS $29.94 02/10/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897138929
Principal investigator 1 Novo Nordisk AS $29.94 02/10/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897145777
Principal investigator 1 Novo Nordisk AS $29.94 02/10/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897145781
Principal investigator 1 Novo Nordisk AS $29.94 02/10/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897146279
Principal investigator 1 Novo Nordisk AS $29.94 02/10/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897146683
Principal investigator 1 Novo Nordisk AS $29.94 02/10/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897146695
Principal investigator 1 Novo Nordisk AS $200.00 02/07/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897138077
Principal investigator 1 Novo Nordisk AS $17,681.13 02/04/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897092295
Principal investigator 1 Novo Nordisk AS $899.10 01/31/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 896961513
Principal investigator 1 Novo Nordisk AS $899.10 01/31/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897001821
Principal investigator 1 Novo Nordisk AS $899.10 01/31/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897001825
Principal investigator 1 Novo Nordisk AS $899.10 01/31/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897087383
Principal investigator 1 Novo Nordisk AS $899.10 01/31/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897186899
Principal investigator 1 Novo Nordisk AS $899.10 01/31/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897188593
Principal investigator 1 Novo Nordisk AS $27.41 01/20/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897014257
Principal investigator 1 Novo Nordisk AS $27.41 01/20/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897049542
Principal investigator 1 Novo Nordisk AS $27.41 01/19/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897146591
Principal investigator 1 Novo Nordisk AS $25.06 01/18/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 896953692
Principal investigator 1 Eli Lilly and Company $3,743.00 01/11/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY PA
A PHASE 2 STUDY OF ONCE-WEEKLY LY3437943 COMPARED WITH PLACEBO IN PARTICIPANTS WHO HAVE OBESITY OR ARE OVERWEIGHT WITH WEIGHT-RELATED COMORBIDITIES No dispute reported 06/30/2026 917841583
Principal investigator 1 Novo Nordisk AS $27.41 01/10/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897049539
Principal investigator 1 Novo Nordisk AS $27.41 01/06/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897092303
Principal investigator 1 Novo Nordisk AS $27.41 01/05/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 897146671
Principal investigator 1 Eli Lilly and Company $225,710.00 01/03/2022 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY PA
A PHASE 2 STUDY OF ONCE-WEEKLY LY3437943 COMPARED WITH PLACEBO IN PARTICIPANTS WHO HAVE OBESITY OR ARE OVERWEIGHT WITH WEIGHT-RELATED COMORBIDITIES No dispute reported 06/30/2026 917843067